[ Price : $8.95]
FDA notifies Cell Therapeutics that a resubmitted NDA for pixantrone to treat non-Hodgkins lymphoma is considered a complete.[ Price : $8.95]
FDA warns Novartis of CGMP violations at three of its Sandoz drug manufacturing facilities.[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites Akzo Nobel Chemicals, Beckman Coulter, Coco Kefir, DreamLife, GD Designs, H&A Mu...[ Price : $8.95]
FDA warns Akzo Nobel Chemicals about CGMP violations in its Mexican API manufacturing facility.[ Price : $8.95]
FDA is expected to rule this week on whether Tevas Plan B emergency contraceptive can be sold openly on store shelves.[ Price : $8.95]
FDA and the Federal Trade Commission issue seven Warning Letters to companies marketing OTC homeopathic human chorionic gonadotrop...[ Price : $8.95]
Sen. Scott Brown (R-MA) introduces a bill to streamline CDRH's de novo classification process for medical devices.[ Price : $8.95]
FDA ORA chief Howard Sklamberg tells an FDLI conference that the agency's enforcement speed is a top priority for 2012.